Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
EVH 
Evolent Health Inc (EVH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: EVH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $15.46
1 Year Target Price $15.46
| 9 | Strong Buy |
| 4 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -37.69% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 999.67M USD | Price to earnings Ratio - | 1Y Target Price 15.46 |
Price to earnings Ratio - | 1Y Target Price 15.46 | ||
Volume (30-day avg) 14 | Beta 0.73 | 52 Weeks Range 7.06 - 31.67 | Updated Date 09/16/2025 |
52 Weeks Range 7.06 - 31.67 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.61 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -5.94% | Operating Margin (TTM) 0.64% |
Management Effectiveness
Return on Assets (TTM) -0.21% | Return on Equity (TTM) -11.04% |
Valuation
Trailing PE - | Forward PE 21.6 | Enterprise Value 1748257637 | Price to Sales(TTM) 0.46 |
Enterprise Value 1748257637 | Price to Sales(TTM) 0.46 | ||
Enterprise Value to Revenue 0.8 | Enterprise Value to EBITDA 200.37 | Shares Outstanding 115971000 | Shares Floating 91317991 |
Shares Outstanding 115971000 | Shares Floating 91317991 | ||
Percent Insiders 1.54 | Percent Institutions 108.7 |
Upturn AI SWOT
Evolent Health Inc
Company Overview
History and Background
Evolent Health was founded in 2011. It partners with health plans and providers to improve clinical and financial performance through an integrated value-based care platform. It has grown through strategic partnerships and acquisitions, focusing on population health management and administrative simplification.
Core Business Areas
- Evolent Health Services: Offers a suite of services including utilization management, care management, and risk adjustment to help health plans and providers improve efficiency and quality.
- New Century Health: Specializes in oncology and cardiology care management, providing clinical decision support and cost management solutions.
- Vital Decisions: Provides advance care planning and end-of-life care services to improve patient outcomes and reduce unnecessary healthcare spending.
Leadership and Structure
Evolent Health is led by a CEO and executive team. The organizational structure includes departments for operations, technology, finance, and business development. The company operates with a focus on client relationships and service delivery.
Top Products and Market Share
Key Offerings
- Evolent Care Management: Care management solutions designed to improve patient outcomes and reduce costs. Market share data is difficult to specify precisely, but Evolent competes with companies like Optum and Signify Health for market share in value based care. Revenue contribution is significant, but specific numbers are proprietary. Competitors include Optum (UNH) and Signify Health (CVS).
- Evolent Value-Based Care Platform: Technology platform enabling health plans and providers to manage value-based care arrangements. Market share is growing, but specific market share is hard to specify. Revenue contribution is significant, but specific numbers are proprietary. Competitors include Cerner (ORCL) and Epic.
- Evolent Population Health Management: Population health management solutions aimed at improving the health of specific populations. Market share is growing, but specific numbers are proprietary. Competitors include Conifer Health Solutions and Allscripts (MDRX).
Market Dynamics
Industry Overview
The healthcare industry is undergoing a shift towards value-based care, driven by rising costs and a focus on improving patient outcomes. Technology and analytics are playing an increasing role in managing patient populations and coordinating care.
Positioning
Evolent Health is positioned as a leading provider of value-based care solutions, partnering with health plans and providers to improve clinical and financial performance. Evolent has a growing market share but still faces stiff competition from much larger players.
Total Addressable Market (TAM)
The TAM for value-based care solutions is estimated to be in the tens of billions of dollars annually. Evolent is well-positioned to capture a significant share of this market due to its comprehensive service offerings and focus on client relationships.
Upturn SWOT Analysis
Strengths
- Strong client relationships
- Comprehensive value-based care platform
- Experienced management team
- Focus on innovation
- Expertise in healthcare analytics
Weaknesses
- Reliance on key clients
- Competition from larger players
- Integration risks from acquisitions
- Vulnerability to healthcare regulatory changes
Opportunities
- Expansion into new markets
- Growth in value-based care adoption
- Partnerships with other healthcare providers
- Development of new products and services
- Increased demand for population health management
Threats
- Increased competition
- Changes in healthcare regulations
- Economic downturn
- Cybersecurity risks
- Data privacy concerns
Competitors and Market Share
Key Competitors
- UNH
- CVS
- MOHO
- DXC
Competitive Landscape
Evolent Health competes with a mix of large healthcare companies and smaller, specialized providers. Evolent's competitive advantages include its comprehensive value-based care platform and focus on client relationships. Evolent is smaller than most of its main competitors.
Major Acquisitions
New Century Health
- Year: 2018
- Acquisition Price (USD millions): 200
- Strategic Rationale: Expanded Evolent's presence in oncology and cardiology care management.
Growth Trajectory and Initiatives
Historical Growth: Evolent Health has experienced significant growth in recent years, driven by the increasing adoption of value-based care. This growth has been fueled by strategic partnerships and acquisitions. Please refer to publicly available financial statements for complete and up to date data.
Future Projections: Analyst estimates project continued growth for Evolent Health, driven by the expanding market for value-based care solutions. These estimates are based on various factors, including market trends, company performance, and competitive landscape.
Recent Initiatives: Recent strategic initiatives include expanding partnerships with health plans and providers, developing new products and services, and investing in technology and analytics.
Summary
Evolent Health is a growing player in the value-based care market, with a strong client base and comprehensive service offerings. Its growth is driven by market trends and strategic initiatives. However, Evolent faces competition from larger players and needs to manage integration risks from acquisitions to be successful.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Publicly Available Financial Statements
- Analyst Reports
- Industry Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is approximate and may vary. All financial figures should be verified with the company's official filings.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Evolent Health Inc
Exchange NYSE | Headquaters Arlington, VA, United States | ||
IPO Launch date 2015-06-05 | Co-Founder, CEO & Director Mr. Seth Barrie Blackley | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4500 | Website https://www.evolent.com |
Full time employees 4500 | Website https://www.evolent.com | ||
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.